TY - JOUR
T1 - Phytochemical analysis and biological investigation of Cheilanthes tenuifolia (Burm.f.) Swartz
AU - Juhi, Umme Habiba
AU - El-Nashar, Heba A.S.
AU - Al Faruq, Abdullah
AU - Bhuia, Md Shimul
AU - Sultana, Irin
AU - Alam, Syedul
AU - Abuyousef, Farah
AU - Saleh, Na’il
AU - El-Shazly, Mohamed
AU - Islam, Muhammad Torequl
N1 - Publisher Copyright:
Copyright © 2024 Juhi, El-Nashar, Al Faruq, Bhuia, Sultana, Alam, Abuyousef, Saleh, El-Shazly and Islam.
PY - 2024
Y1 - 2024
N2 - Introduction: Cheilanthes tenuifolia is an evergreen ornamental small fern, belonging to the family Pteridaceae, that grows in warm and rocky regions worldwide. Many species of Cheilanthes genus are evidently endowed with important phytochemicals and bioactivities. This study aimed to perform a preliminary phytochemical analysis of Cheilanthes tenuifolia leaves alongside an evaluation of free radical scavenging, anti-inflammatory, antimicrobial, and clot lysis activities of extract fractions. Materials and methods: A preliminary phytochemical analysis was done after fractionation of ethanolic extract (ECT) with n-hexane (HCT) and chloroform (CCT). Then, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, egg albumin and RBC membrane stabilization tests, disc diffusion, and human blood clot lysis assays were performed. Results: Phytochemical investigations suggested that the plant is rich in alkaloids, glycosides, tannins, and flavonoids. All obtained fractions exhibited concentration-dependent radical scavenging, inhibition of egg protein denaturation and RBC membrane lysis capacities. Except for antifungal tests, ECT exhibited better DPPH radical scavenging, anti-inflammatory, antibacterial, and clot lysis capacities than HCT and CCT fractions. However, all fractions exhibited a mild anti-inflammatory activity. Conclusion: C. tenuifolia might be a good source of antioxidant, anti-microbial, and anti-atherothrombotic agents. Further studies are required to isolate and characterize the active principles liable for each bioactivity, along with possible molecular interactions.
AB - Introduction: Cheilanthes tenuifolia is an evergreen ornamental small fern, belonging to the family Pteridaceae, that grows in warm and rocky regions worldwide. Many species of Cheilanthes genus are evidently endowed with important phytochemicals and bioactivities. This study aimed to perform a preliminary phytochemical analysis of Cheilanthes tenuifolia leaves alongside an evaluation of free radical scavenging, anti-inflammatory, antimicrobial, and clot lysis activities of extract fractions. Materials and methods: A preliminary phytochemical analysis was done after fractionation of ethanolic extract (ECT) with n-hexane (HCT) and chloroform (CCT). Then, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, egg albumin and RBC membrane stabilization tests, disc diffusion, and human blood clot lysis assays were performed. Results: Phytochemical investigations suggested that the plant is rich in alkaloids, glycosides, tannins, and flavonoids. All obtained fractions exhibited concentration-dependent radical scavenging, inhibition of egg protein denaturation and RBC membrane lysis capacities. Except for antifungal tests, ECT exhibited better DPPH radical scavenging, anti-inflammatory, antibacterial, and clot lysis capacities than HCT and CCT fractions. However, all fractions exhibited a mild anti-inflammatory activity. Conclusion: C. tenuifolia might be a good source of antioxidant, anti-microbial, and anti-atherothrombotic agents. Further studies are required to isolate and characterize the active principles liable for each bioactivity, along with possible molecular interactions.
KW - Cheilanthes tenuifolia
KW - anti-atherothrombotic
KW - anti-inflammatory
KW - antimicrobial
KW - membrane stabilization
KW - radical scavenging
KW - secondary metabolites
UR - http://www.scopus.com/inward/record.url?scp=85190589723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85190589723&partnerID=8YFLogxK
U2 - 10.3389/fphar.2024.1366889
DO - 10.3389/fphar.2024.1366889
M3 - Article
AN - SCOPUS:85190589723
SN - 1663-9812
VL - 15
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 1366889
ER -